Promimic AB (OSTO:PRO) Beneish M-Score: -2.60 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:PRO Promimic AB OSTO:PRO
68 GF Score
Price kr10.30
GF Value kr31.77
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Promimic AB Beneish M-Score?

Promimic AB OSTO:PRO 68 Beneish M-Score is -2.60 as of Jul. 14, 2026. GuruFocus rates OSTO:PRO with a GF Score™ of 68/100 and a GF Value™ of kr31.77 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 763 Medical Devices & Instruments companies, Promimic AB ranks better than 52.29% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.6 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Promimic AB's Beneish M-Score or its related term are showing as below:

OSTO:PRO' s Beneish M-Score Range Over the Past 10 Years
Min: -2.6   Med: -2.05   Max: -1.64
Current: -2.6

During the past 7 years, the highest Beneish M-Score of Promimic AB was -1.64. The lowest was -2.60. And the median was -2.05.


Promimic AB Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Promimic AB's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Promimic AB Beneish M-Score Chart

Promimic AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -2.17 -1.98 -2.10 -2.19 -2.60

Promimic AB Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.60 0.00

OSTO:PRO vs ABT, SYK, MDT: Beneish M-Score Comparison

For the Medical Devices subindustry, Promimic AB's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Promimic AB Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Promimic AB's Beneish M-Score falls into.


OSTO:PRO
68GF Score
Promimic AB OSTO:PRO
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Promimic AB Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Promimic AB for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9337+0.528 * 1.0965+0.404 * 1.4265+0.892 * 1.0101+0.115 * 1.0581
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.060216-0.327 * 1.064
=-2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was kr20.55 Mil.
Revenue was kr44.42 Mil.
Gross Profit was kr44.20 Mil.
Total Current Assets was kr42.08 Mil.
Total Assets was kr75.71 Mil.
Property, Plant and Equipment(Net PPE) was kr10.82 Mil.
Depreciation, Depletion and Amortization(DDA) was kr4.77 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr16.61 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.
Net Income was kr-8.75 Mil.
Gross Profit was kr0.00 Mil.
Cash Flow from Operations was kr-4.20 Mil.
Total Receivables was kr21.79 Mil.
Revenue was kr43.98 Mil.
Gross Profit was kr47.99 Mil.
Total Current Assets was kr58.85 Mil.
Total Assets was kr88.07 Mil.
Property, Plant and Equipment(Net PPE) was kr10.61 Mil.
Depreciation, Depletion and Amortization(DDA) was kr5.08 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.00 Mil.
Total Current Liabilities was kr18.15 Mil.
Long-Term Debt & Capital Lease Obligation was kr0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(20.549 / 44.42) / (21.789 / 43.976)
=0.462607 / 0.495475
=0.9337

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(47.985 / 43.976) / (44.203 / 44.42)
=1.091163 / 0.995115
=1.0965

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (42.08 + 10.818) / 75.711) / (1 - (58.853 + 10.612) / 88.067)
=0.301317 / 0.211226
=1.4265

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=44.42 / 43.976
=1.0101

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(5.079 / (5.079 + 10.612)) / (4.768 / (4.768 + 10.818))
=0.323689 / 0.305916
=1.0581

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 44.42) / (0 / 43.976)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 16.605) / 75.711) / ((0 + 18.153) / 88.067)
=0.219321 / 0.206127
=1.064

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-8.754 - 0 - -4.195) / 75.711
=-0.060216

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Promimic AB has a M-score of -2.60 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.60 mean?
Promimic AB (OSTO:PRO) has a Beneish M-Score of -2.60 as of Jul. 14, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Promimic AB and its competitors. According to the industry distribution chart, Promimic AB ranks #364 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 47.7%.
Is Promimic AB's Beneish M-Score too high?
Promimic AB's current Beneish M-Score is -2.60. Based on the distribution chart, Promimic AB ranks #364 out of 763 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Promimic AB has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Promimic AB's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Promimic AB ranks #364 out of 763 companies for Beneish M-Score. This puts Promimic AB in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Promimic AB and its competitors. Promimic AB's current Beneish M-Score is -2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promimic AB stock overvalued right now?
Based on GuruFocus' analysis, Promimic AB (OSTO:PRO) is currently considered Significantly Undervalued. The stock's GF Value™ is kr31.77, compared to a current price of kr10.30 — trading 67.6% below its estimated fair value. The current Beneish M-Score is -2.60. Promimic AB's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Promimic AB (OSTO:PRO), the current Beneish M-Score is -2.60 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Promimic AB (OSTO:PRO) Overvalued in 2026?

Based on GuruFocus' analysis, Promimic AB stock appears to be undervalued. The current stock price of kr10.30 is trading 67.6% below its estimated GF Value™ of kr31.77. GuruFocus considers Promimic AB to be Significantly Undervalued.

Key valuation signals for OSTO:PRO:

  • Beneish M-Score: -2.60
  • GF Value™: kr31.77 vs. price of kr10.30 (67.6% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the OSTO:PRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Promimic AB Business Description

Address care of AstraZeneca Research and Development Molndal, AZ BioVentureHub, Molndal, SWE, 431 83
Promimic AB is a biomaterial company producing a nano-thin surface for all implant materials for faster osseointegration.
68GF Score

Get the complete analysis for OSTO:PRO

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.30
Price
kr31.77
GF Value